Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pergoveris replacement of male mini-puberty in infants with hypogonadotropic hypogonadism
ISRCTN13007297Phase 2Completed
- Sponsor
- Athens Medical Center
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of luteinizing hormone in hypogonadotropic hypogonadism (HH), sponsored by Athens Medical Center. Primary endpoints: Stretched penile length, Testicular volume by orchidometer and 1 more. Started Jun 2009; status: completed.
02
Drugs
luteinizing hormone
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on ISRCTN13007297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13007297.